BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38031136)

  • 1. ARHGAP44-mediated regulation of the p53/C-myc/Cyclin D1 pathway in modulating the malignant biological behavior of osteosarcoma cells.
    Li S; Xue J; Zhang H; Shang G
    J Orthop Surg Res; 2023 Nov; 18(1):910. PubMed ID: 38031136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
    Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant p53 promotes cell spreading and migration via ARHGAP44.
    Xu J; Jiao J; Xu W; Ji L; Jiang D; Xie S; Kubra S; Li X; Fu J; Xiao J; Zhang B
    Sci China Life Sci; 2017 Sep; 60(9):1019-1029. PubMed ID: 28527113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
    Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
    Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3β/β-catenin/cyclin D1 signaling pathway.
    Liu Y; Xi Y; Chen G; Wu X; He M
    J Orthop Surg Res; 2020 Jun; 15(1):226. PubMed ID: 32552851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells.
    Wang L; Zhao Y; Wu Q; Guan Y; Wu X
    Mol Med Rep; 2018 Mar; 17(3):4299-4306. PubMed ID: 29363722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARHGAP44 expression is associated with the metastasis of osteosarcoma and is a promising prognostic biomarker.
    Hu S; Wang W
    J Orthop Res; 2023 Jun; 41(6):1348-1355. PubMed ID: 36317850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
    Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression.
    Guan X; Xu Y; Zheng J
    Oncol Rep; 2020 Dec; 44(6):2465-2474. PubMed ID: 33125146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR‑181b‑p53 negative feedback axis regulates osteosarcoma cell proliferation and invasion.
    Wan J; Long F; Zhang C; Liu Y
    Int J Mol Med; 2020 Jun; 45(6):1803-1813. PubMed ID: 32236583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA LINC01296 regulates the proliferation, metastasis and cell cycle of osteosarcoma through cyclin D1.
    Yu X; Pang L; Yang T; Liu P
    Oncol Rep; 2018 Nov; 40(5):2507-2514. PubMed ID: 30226542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell.
    Meng Q; Zheng M; Liu H; Song C; Zhang W; Yan J; Qin L; Liu X
    Mol Cell Biochem; 2013 Jan; 373(1-2):201-10. PubMed ID: 23108792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
    Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
    Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma.
    Meng Q; Zhao J; Liu H; Zhou G; Zhang W; Xu X; Zheng M
    Tumour Biol; 2014 Dec; 35(12):12265-74. PubMed ID: 25168370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
    Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
    Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-449a Sponges Cyclin D1 Expression and Suppresses Phosphorylation of Retinoblastoma Protein against Osteosarcoma.
    Sun Z; Gao M; Li Z; Hao Q; Li L
    Crit Rev Eukaryot Gene Expr; 2021; 31(3):5-19. PubMed ID: 34369711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
    Liu ZB; Wang JA; Lv RQ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
    Jiang H; Guo W; Yuan S; Song L
    Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.